Skip to main content

Table 3 Antibiotic resistance profile

From: Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum Beta-lactamase in Klebsiella pneumoniae in Egypt

  Panel of antibiotic tested
  Disk diffusion* ESBL Confirmation† E-test‡
  Ampicillin (AM) Imipenem (IPM) Cefepime (FEP) Cephalothin (CF) Ceftriaxone (CRO) Cefpodoxime (CPD) CAZ CAZ/CLA ZONE CTX CTX/CLA zone Sulfamethoxazole (SXT) Ceftazidime (TZ) Cefepime (PM0 Cephalothin (CE)
N(%) Cases with resistance phenotype 65 (100) 1 (3) 24 (37) 65 (100) 61 (94) 65 (100) 65 (100) 0 (0) 63 (97) 1 (1.5) 32 (49) 64 (98) 9 (14) 65 (100)
  1. The table is divided into three major categories to show the number and percent [N (%) ] of cases with ESBL phenotype by Disc diffusion*, double disc synergy test (for ESBL confirmation)† and E test results ‡ to SXT and other third generation antibiotics.